Pathos
AI-driven precision oncology drug development
CORE INFO
Pathos is a biotechnology company that uses artificial intelligence to develop precision oncology drugs, aiming to improve the efficiency of clinical trials and deliver effective therapies to cancer patients.
- Pathos achieved a valuation of approximately $1.6 billion following its Series D financing round.pathos.com
- The company secured $365 million in its latest Series D funding round announced in May 2025.pathos.com
WHY WE WOULD WORK AT PATHOS
Transform Patient Outcomes
Join a mission-driven team dedicated to revolutionizing oncology drug development, enhancing patient outcomes through AI-driven precision therapies.
Innovative Technology
Work with a proprietary AI-enabled platform that integrates multimodal data, optimizing drug development processes and accelerating clinical trials.
Strong Financial Backing
Benefit from Pathos's impressive $365 million Series D funding, ensuring robust resources for growth and innovation in biotechnology.
Collaborative Culture
Be part of a dynamic team of approximately 81 employees, fostering collaboration and innovation in a fast-paced, supportive environment.
Achieve Unicorn Status
Contribute to a company that achieved unicorn status with a valuation of $1.6 billion in just over three years, showcasing rapid growth and market impact.
Redefine Drug Development
Help redefine traditional trial-and-error methods in drug development, leveraging advanced AI and extensive oncology data to create effective therapies.
MARKET AND TRACTION
TOTAL ADDRESSABLE MARKET
KEY METRICS
✦ KEY METRICGROWTH TACTICS
COMPETITIVE ADVANTAGE
MARKET POSITION
PRODUCT AND TECH
AI-Enabled Platform
Pathos utilizes a proprietary AI-enabled platform that integrates multimodal data, including genomics, transcriptomics, imaging, and clinical outcomes. This technology enhances the efficiency and accuracy of drug development processes in precision oncology.
Precision Oncology Development
The company specializes in precision oncology drug development, aiming to transform traditional methods by leveraging AI and extensive oncology patient data. This approach accelerates the delivery of effective therapies to patients.
Biological Modeling Techniques
Pathos employs advanced biological modeling techniques to simulate and predict drug interactions and patient responses. This innovative methodology reduces reliance on trial-and-error approaches in drug development.
Clinical Trial Optimization
By integrating comprehensive patient data, Pathos optimizes clinical trial processes, enhancing their effectiveness and reducing time to market for new therapies. This focus on optimization is crucial for improving patient outcomes.
Data Integration Capabilities
The integration of multimodal data sources allows Pathos to create a holistic view of patient profiles and treatment responses. This capability is essential for developing targeted therapies that are more likely to succeed in clinical settings.